COMMON STOCK	9 Months Ended
Sep. 30, 2013
Common Stock
COMMON STOCK	NOTE 7. COMMON STOCK The total number of authorized shares of the Company’s common stock is 750,000,000 shares, $0.001 par value per share. As of September 30, 2013, there were 17,804,724 common shares issued and outstanding. Each share of the Company's common stock is entitled to equal dividends and distributions per share with respect to the common stock when, as and if declared by the Company's board of directors. No holders of any shares of the Company's common stock has a preemptive right to subscribe for any of the Company's securities, nor are any shares of the Company's common stock subject to redemption or convertible into other securities. Upon liquidation, dissolution or winding-up of the Company and after payment of creditors and preferred shareholders of the Company, if any, the assets of the Company will be divided pro rata on a share-for-share basis among the holders of the Company's common stock. Each share of the Company's common stock is entitled to one vote. Shares of the Company's common stock do not possess any cumulative voting rights. During the nine months ended September 30, 2013, a total of 189,054 shares of the Company's Series A Preferred Stock were converted into 189,054 shares of our common stock on a one-for-one basis. Additionally, warrants to purchase 628,000 shares of the Company's common stock were exercised for a net of 306,763 shares of common stock (when adjusting for a cashless exercise of certain of such warrants and the payment, in shares of common stock ($993,750) and cash ($42,750), of an aggregate exercise price of $1,036,500 in connection with such exercises) and 306,763 shares of common stock were issued to the warrant holders in connection with such exercises; and options to purchase 405,000 shares of common stock were exercised for a net of 330,050 shares of common stock (when adjusting for a cashless exercise of such certain of such options and the payment, in shares of common stock, of an aggregate exercise price of $235,500, along with $12,500 of exercise prices paid in cash in connection with such exercises) and 330,050 shares of common stock were issued to the option holders in connection with such exercises. During the nine months ending September 30, 2013, there was a dispute as to the expiration date of certain options previously granted. As a result, a settlement was made with the option holder and 13,393 shares of common stock were issued to settle the dispute (which totaled the shares which would have been due upon a cashless exercise of such disputed options (had such otpions been outstanding) and the payment, in shares of common stock, of an aggregate exercise price of $46,000, in connection with such exercise).

NOTE 7. COMMON STOCK

The total number of authorized shares of the Company’s common stock is 750,000,000 shares, $0.001 par value per share. As of September 30, 2013, there were 17,804,724 common shares issued and outstanding.

Each share of the Company's common stock is entitled to equal dividends and distributions per share with respect to the common stock when, as and if declared by the Company's board of directors. No holders of any shares of the Company's common stock has a preemptive right to subscribe for any of the Company's securities, nor are any shares of the Company's common stock subject to redemption or convertible into other securities. Upon liquidation, dissolution or winding-up of the Company and after payment of creditors and preferred shareholders of the Company, if any, the assets of the Company will be divided pro rata on a share-for-share basis among the holders of the Company's common stock. Each share of the Company's common stock is entitled to one vote. Shares of the Company's common stock do not possess any cumulative voting rights.

During the nine months ended September 30, 2013, a total of 189,054 shares of the Company's Series A Preferred Stock were converted into 189,054 shares of our common stock on a one-for-one basis. Additionally, warrants to purchase 628,000 shares of the Company's common stock were exercised for a net of 306,763 shares of common stock (when adjusting for a cashless exercise of certain of such warrants and the payment, in shares of common stock ($993,750) and cash ($42,750), of an aggregate exercise price of $1,036,500 in connection with such exercises) and 306,763 shares of common stock were issued to the warrant holders in connection with such exercises; and options to purchase 405,000 shares of common stock were exercised for a net of 330,050 shares of common stock (when adjusting for a cashless exercise of such certain of such options and the payment, in shares of common stock, of an aggregate exercise price of $235,500, along with $12,500 of exercise prices paid in cash in connection with such exercises) and 330,050 shares of common stock were issued to the option holders in connection with such exercises.

During the nine months ending September 30, 2013, there was a dispute as to the expiration date of certain options previously granted. As a result, a settlement was made with the option holder and 13,393 shares of common stock were issued to settle the dispute (which totaled the shares which would have been due upon a cashless exercise of such disputed options (had such otpions been outstanding) and the payment, in shares of common stock, of an aggregate exercise price of $46,000, in connection with such exercise).